G. Aus et al., INFLUENCE OF BENIGN PROSTATIC HYPERPLASIA, TESTOSTERONE AND AGE ON SERUM LEVELS OF PROSTATE-SPECIFIC ANTIGEN, Scandinavian journal of urology and nephrology, 28(4), 1994, pp. 379-384
Prostate specific antigen (PSA) and PSA-density (PSAd) were studied in
120 symptomatic patients with benign prostatic hyperplasia at digital
rectal examination. PSA and PSAd were measured before and 3 months af
ter transurethral resection. Comparisons were made between patients in
whom histologic examination showed benign hyperplasia and those with
histologically demonstrated prostatic cancer. The influence of age and
of serum testosterone on PSA and PSAd was determined. PSAd in benign
prostatic hyperplasia was the same in the transition zone (the adenoma
s) and the peripheral zone (mean 0.065), indicating no increased synth
esis or leakage of PSA. PSAd with cut-off value 0.10 ng x ml(-1) cc(-1
) showed higher sensitivity and positive predictive value (75% vs 50%
and 0.33 vs 0.15, respectively) in nonpalpable prostatic cancer than d
id PSA with cut-off at 4 ng x ml(-1). No statistically significant inf
luence of testosterone and/or age on serum-PSA or PSAd was found.